This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Baxter International at a 52-Week High on Solid Product Line
by Zacks Equity Research
Share price of Deerfield, IL-based Baxter International Inc. (BAX) scaled a new 52-week high of $59.49 on May 30, eventually closing a bit lower at $59.35.
Intuitive Surgical da Vinci X Surgical System Okayed by FDA
by Zacks Equity Research
Headquartered in Sunnyvale, CA, Intuitive Surgical Inc. (ISRG) recently announced that the da Vinci X Surgical System, an upgrade to its flagship da Vinci Xi surgical platform, has been cleared by the FDA.
Boston Scientific Trades Up on Strong Q1 amid Recall Issues
by Zacks Equity Research
On May 29 2017, we issued an updated research report on leading medical devices company, Boston Scientific Corporation (BSX).
IDEXX Laboratories Global Growth Solid amid Currency Woes
by Zacks Equity Research
On May 29, we issued an updated research report on leading molecular diagnostic company, IDEXX Laboratories, Inc. (IDXX).
Quintiles IMS Holdings (Q) to Repurchase 10.6M Common Share
by Zacks Equity Research
Quintiles IMS Holdings, Inc. (Q) announced that it will repurchase 10,571,003 shares of its common stock.
NuVasive Aims for Innovation, Global Growth amid Woes
by Zacks Equity Research
On May 29, we issued an updated research report on San Diego, CA-based NuVasive, Inc. (NUVA).
Inogen (INGN) Hits a 52-Week High on Solid Q1, Upbeat View
by Zacks Equity Research
Shares of Inogen Inc. (INGN) rallied to a new 52-week high of $89.54 on May 26, eventually closing a tad bit lower at $87.93. This represents a strong one-year return of about 84.6%, much better than the S&P 500's return of roughly 9.7%.
Varian Medical at a 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Share price of Varian Medical Systems Inc. (VAR), headquartered in Palo Alto, CA, scaled a new 52-week high of $97.96 on May 26, eventually closing a bit lower at $97.87.
Thermo Fisher on an Acquisition Spree, Competition Rife
by Zacks Equity Research
On May 29, we issued an updated research report on Waltham, MA-based Thermo Fisher Scientific, Inc. (TMO), a scientific instrument maker and a world leader in serving science.
Myriad Genetics Gets Extended Coverage for Prolaris Test
by Zacks Equity Research
Molecular diagnostics and personalized medicine major Myriad Genetics, Inc. (MYGN) recently received extended Medicare coverage for its Prolasis test.
Why WellCare (WCG) Stock Should Be in Your Portfolio Now
by Zacks Equity Research
Leading managed care company WellCare Health Plans, Inc.'s (WCG) business strategies should continue to support growth.
Henry Schein (HSIC) Rides on Global Growth, Strategic Deals
by Zacks Equity Research
On May 25 2017, we issued an updated research report on Melville, NY-based Henry Schein, Inc. (HSIC).
Patterson Companies (PDCO) Earnings Beat Estimates in Q4
by Zacks Equity Research
Patterson Companies Inc. (PDCO) reported fourth-quarter fiscal 2017 adjusted earnings of 69 cents per share from continuing operations, which outpaced the Zacks Consensus Estimate of 64 cents.
UnitedHealth's (UNH) Business Unit Collaborates with Merck
by Zacks Equity Research
UnitedHealth Group, Inc.???s (UNH) information and technology-enabled health services business "Optum" recently announced its collaboration with Merck & Co. Inc (MRK).
Veeva Systems (VEEV) Beats Q1 Earnings, Revenues Estimates
by Zacks Equity Research
Veeva Systems Inc. (VEEV) reported first-quarter fiscal 2018, adjusted earnings of 14 cents per share, ending Apr 30, 2017.
Stryker (SYK) at 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Share price of Stryker Corporation (SYK), headquartered in Kalamazoo, MI, scaled a new 52-week high of $141.21 on May 25, eventually closing a little lower at $140.85.
Quest Diagnostics Hits a 52-Week High on Solid Prospects
by Zacks Equity Research
Share price of Madison, NJ-based Quest Diagnostics, Inc. (DGX) scaled a new 52-week high of $108.52 on May 16, eventually closing a bit lower at $108.14.
Inogen, Acacia Research and Ulta Beauty highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Inogen, Acacia Research and Ulta Beauty highlighted as Zacks Bull and Bear of the Day
Bull of the Day: Inogen (INGN)
by Kevin Cook
Years of breathing room for the leader in portable oxygen concentrators (POCs) to expand sales at a 15% CAGR
Align Technology Rises with Invisalign, SmartTrack Patents
by Zacks Equity Research
Align Technology (ALGN) has received two U.S. Patents from the United States Patent and Trademark Office (USPTO) for its SmartTrack clear aligner material.
Medtronic (MDT) Tops Q4 Earnings, Sales on Balanced Growth
by Zacks Equity Research
Medtronic plc's (MDT) fourth-quarter fiscal 2017 adjusted earnings per share came in at $1.33, a couple of cents ahead of the Zacks Consensus Estimate.
Medtronic Puts First Patient in IN.PACT AV Access DCB Study
by Zacks Equity Research
Medtronic plc (MDT), announced the first patient enrollment under its IN.PACT AV Access Drug-Coated Balloon (DCB) study for patients with end-stage renal disease (ESRD).
Boston Scientific (BSX) BT Study on Asthma Results Positive
by Zacks Equity Research
Boston Scientific Corporation (BSX) recently unveiled positive outcome from the Post Approval Clinical Trial Evaluating Bronchial Thermoplasty (BT) in Severe Persistent Asthma (PAS2) study.
Varian (VAR) ProBeam Proton Therapy System Now in Thailand
by Zacks Equity Research
Leading manufacturer of medical devices and software, Varian Medical Systems, Inc. (VAR) has sealed another international deal for its Proton therapy platform.
LabCorp Offers Sera's PreTRM to Assess Preterm Birth Risk
by Zacks Equity Research
Leading diagnostics testing company LabCorp (LH) recently announced the availability of Sera Prognostics, Inc.'s PreTRM test at its laboratories in the U.S.